No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
IKNA Ikena Oncology
- 1.550
- -0.060-3.73%
Close Dec 20 16:00 ET
- 1.550
- 0.0000.00%
Post 16:04 ET
74.80MMarket Cap-1.26P/E (TTM)
1.620High1.550Low207.31KVolume1.620Open1.610Pre Close325.23KTurnover1.50%Turnover RatioLossP/E (Static)48.26MShares2.29052wk High0.56P/B21.50MFloat Cap1.22052wk Low--Dividend TTM13.87MShs Float37.610Historical High--Div YieldTTM4.35%Amplitude1.020Historical Low1.568Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
H.C. Wainwright Maintains Ikena Oncology(IKNA.US) With Buy Rating, Maintains Target Price $4
Buy Rating for Ikena Oncology Driven by Promising IK-595 Developments
Ikena Oncology Third Quarter 2024 Earnings: US$0.21 Loss per Share (Vs US$0.40 Loss in 3Q 2023)
Ikena Oncology Reports Strategic Realignment and Financial Performance
Ikena Oncology GAAP EPS of -$0.21 Beats by $0.06
Ikena Oncology 3Q Loss $10.2M >IKNA
Heat List
US
Overall
Symbol
Price
% Chg
No Data